Tilawan, Jeromie T.

HRN: 27-58-79  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2025
CEFUROXIME 500MG (TAB)
08/07/2025
08/13/2025
PO
500 Mg
BID
CAP LR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: